Home >Drug List>Letermovir>Indications of Letermovir

Indications of Letermovir

1. Prevention of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

Letermovir tablets are indicated for the prevention of cytomegalovirus (CMV) infection and disease in CMV-seropositive adult and pediatric allogeneic hematopoietic stem cell transplant recipients aged 6 months and older weighing at least 6 kg.

2. Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients

Letermovir tablets are indicated for the prevention of CMV disease in high-risk adult and pediatric kidney transplant recipients aged 12 years and older weighing at least 40 kg.